Modifizierte L-Nukleinsäure

European patent · EP2431377 · Deleted

Register entry

Publication number
EP2431377
Application number
EP10005431
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Oct 25, 2002
Published
Mar 21, 2012
Granted
Apr 19, 2017
Deleted
May 28, 2022
Reason
Annual fee unpaid
IPC classes
C07H 21/00 (2006.01)
G01N 33/53 (2006.01)
C12Q 1/68 (2006.01)
A61K 31/7088 (2006.01)
Priority
EP 01125630 26.10.2001
EP 02017300 01.08.2002
Divided from
EP02783007
Filing language
German
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 28, 2022

    Deleted, fee unpaid

    Published in Swissreg on 28.05.2022

  2. Jul 26, 2017

    Agent entered

    Representative
    Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich

    Published in Swissreg on 26.07.2017

  3. Apr 19, 2017

    Granted

    Published in Swissreg on 19.04.2017

Parties

Holder

Noxxon Pharma AG

Max-Dohrn-Strasse 8-10, 10589 Berlin, DE

Agent

Isler & Pedrazzini AG

Postfach 1772, 8027 Zürich

Inventor

Lange, Christian

13187 Berlin, DE

Eschgfäller, Bernd

90491 Nürnberg, DE

Klussmann, Sven

10585 Berlin, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.